Cita APA (7a ed.)

P, N., & K, V. (2019). Development of anti-HER2-targeted doxorubicin–core-shell chitosan nanoparticles for the treatment of human breast cancer. Dove Medical Press.

Cita Chicago Style (17a ed.)

P, Naruphontjirakul, y Viravaidya-Pasuwat K. Development of Anti-HER2-targeted Doxorubicin–core-shell Chitosan Nanoparticles for the Treatment of Human Breast Cancer. Dove Medical Press, 2019.

Cita MLA (8a ed.)

P, Naruphontjirakul, y Viravaidya-Pasuwat K. Development of Anti-HER2-targeted Doxorubicin–core-shell Chitosan Nanoparticles for the Treatment of Human Breast Cancer. Dove Medical Press, 2019.